| Business Summary | | BSD
Medical
Corporation
is
in
the
business
of
development,
production,
marketing,
and
servicing
of
heat
therapy
(hyperthermia/thermotherapy)
equipment.
BSD
currently
has
11
United
States
patents,
eight
foreign
patents,
and
five
patent
licenses
(which
cover
all
of
its
current
applications
and
products
as
well
as
additional
applications
and
devices).
BSD,
a
biomedical
firm,
was
founded
to
research
the
demonstrated
ability
of
elevated
heat
(hyperthermia)
to
destroy
cancer
cells.
BSD
was
successful
in
developing
and
commercializing
hyperthermia
treatment,
a
breakthrough
therapy
for
both
cancerous
and
benign
diseases. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BSD
Medical
Corporation
develops,
produces,
markets
and
services
systems
used
in
the
treatment
of
cancer
and
other
diseases.
For
the
nine
months
ended
5/31/01,
revenues
increased
5%
to
$1.2
million.
Net
loss
fell
50%
to
$424
thousand.
Revenues
reflect
increased
product
sales.
Lower
loss
also
reflects
lower
S/G/A
costs
due
to
changes
in
the
cycle
of
promotional
expenses
and
the
absence
of
a
$359
thousand
loss
in
equity
earnings
in
TherMatrx,
Inc. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Paul Turner, 53 Chairman,
Sr. VP and CTO | $144K | Hyrum Mead, 53 Pres | 125K | Dixie Sells, 50 VP
of Regulatory Affairs and Corp. Sec. | -- | Ray Lauritzen, 50 VP
of Field Service | -- | Dollar amounts are as of 31-Aug-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|